Skip to main content
Menu
US

Bombesin (6-14), D-Tyr6[125I], 10µCi

Bombesin (6-14), labeled with 125I. Bombesin binds and activates bombesin receptors BBR1, BBR2, and BBR3, and is a tumor marker for lung cancer, gastric cancer, pancreative cancer, and neuroblastoma.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Fresh Lot Days First Monday of each month
Label Position Nominally Labeled
Molecular Weight ~1258
Receptor Bombesin

Bombesin (6-14), labeled with 125I. Bombesin binds and activates bombesin receptors BBR1, BBR2, and BBR3, and is a tumor marker for lung cancer, gastric cancer, pancreative cancer, and neuroblastoma.

For research use only. Not for use in diagnostic procedures.

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 10 µCi
Part #:
NEX377010UC
List Price
USD 2,281.00
Unit Size: 25 µCi
Part #:
NEX377025UC
List Price
USD 4,287.00

Overview

10 µCiQuantities of Bombesin (6-14), D-Tyr6[125I] are available for your research.

We offer radioligands and radiolabeled biomolecules to use as tracers, for radioimmunoassays (RIAs), for autoradiographic visualization, or for performing saturation and competition radioligand binding assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radiolabeled compounds is fully characterized for pharmacological action and validated in binding assays.

Radiochemicals remain the most sensitive method for probing binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NEX377:

  1. Liu, J., Lao, Z.J., Zhang, J., Schaeffer, M.T., Jiang, M.M., Guan, X.M., Van der Ploeg, L.H., Fong, T.M. (2002), Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). Biochemistry, 41 (28): 8954-8960.
  2. Yoshizaki, K., de Bock, V., Solomon, S. (1984), Origin of bombesin-like peptides in human fetal lung. Life Sci, 34 (9): 835-843.

Specifications

Molecular Weight
~1258
Specific Activity
2200.0 Ci/mmol
Application
Drug Discovery & Development
Brand
NEN Radiochemicals
Buffer/Solvent
0.2M NAcetylmethionine, 50mM Phosphoric Acid and 0.25% BSA : 1-propanol (1:1)
Detection Modality
Radiometric
Fresh Lot Days
First Monday of each month
Label Position
Nominally Labeled
Packaging
NENSure vial
Radioisotope
125I
Receptor
Bombesin
Shipping Conditions
Shipped in Dry Ice
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Storage Conditions
-20°C
Therapeutic Area
Cancer
CNS & Neurologic
Unit Size
10 µCi

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Product Info Icon
Product Info
Calendar: NEN® Radiochemicals 2024 Fresh Lot
Scroll Icon